MET and ovarian carcinoma: Met, a cell membrane receptor tyrosine kinase, is also a recognized Wnt target gene and up‐regulated by the regulation of Wnt/β‐catenin signalling cascade.45, 46 On the other hand, Met also plays an important role in the pathogenesis of ovarian cancer.47 So it is meaningful to examine the Met expression in the ovarian cancer when we research the Wnt/β‐catenin pathway.